Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2020-10-29 AGM Information
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
MVP 2020 AGM 2 pages 174.3KB
AGM Information Classification · 95% confidence The document is an ASX announcement dated 30 October 2020 regarding the MVP 2020 Annual General Meeting (AGM) held on 28 October 2020. It provides a link to download and view the AGM proceedings for shareholders and interested parties who could not attend. The document does not contain the AGM materials themselves but rather an announcement about the availability of the AGM content. The document length is short (2425 characters), and it explicitly states that the proceedings can be downloaded via a link, indicating it is an announcement rather than the AGM materials or report itself. Therefore, according to the MENU VS MEAL RULE, this document should be classified as AGM Information (AGM-R).
2020-10-29 English
MVP and MundiPharma cease Australian licensing agreement 2 pages 184.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 30 October 2020 regarding the cessation of a distribution and licensing agreement between MVP and MundiPharma in Australia. It contains no financial statements, no detailed financial analysis, no regulatory certifications, or voting results. The content is a business update about a change in commercial arrangements and strategy. The document length is 3779 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is a report publication announcement or a regulatory filing of a different nature. The content fits best with a Capital/Financing Update (CAP) as it relates to changes in business operations and commercial rights, which impact the company's capital and market strategy.
2020-10-29 English
Chairman's and CEO's Address to Shareholders 3 pages 164.6KB
AGM Information Classification · 95% confidence The document is an ASX announcement dated 28 October 2020 containing addresses by the Chairman and Acting CEO to shareholders. It discusses company performance, leadership changes, business progress, and future outlook. The content is typical of presentations or speeches given at shareholder meetings, focusing on strategic updates and operational highlights rather than detailed financial statements or regulatory compliance information. There is no indication that this is a full annual report, audit report, earnings release, or other formal financial filing. The nature of the document aligns with materials shared during an Annual General Meeting (AGM), such as Chairman and CEO addresses to shareholders. The document length (8783 characters) supports it being a detailed AGM presentation rather than a brief announcement or certification. Therefore, the most appropriate classification is AGM Information (AGM-R).
2020-10-27 English
Results of Meeting 2 pages 155.2KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal communication to the Australian Securities Exchange regarding the results of the 2020 Annual General Meeting (AGM) of Medical Developments International Limited. It includes detailed voting results for various resolutions, referencing compliance with the Corporations Act and ASX Listing Rules. The content focuses on the announcement of voting outcomes rather than the AGM materials or presentations themselves. The document length is short (2749 characters), and it primarily reports the official voting results from the AGM. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-10-27 English
Initial Director's Interest Notice 2 pages 125.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, including appointment date and shareholdings. This is a report of personal share transactions or interests by a company director. The document length is short and focused solely on director's interests, matching the definition of Director's Dealing filings.
2020-10-14 English
Trading Halt 2 pages 211.0KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Medical Developments International Limited regarding a trading halt requested due to significant personnel changes. It references ASX listing rule 17.1 and is a formal request letter for the trading halt. There is no financial data, report, or detailed announcement included, only a notification of the trading halt pending a future announcement. The document is short (2151 characters) and serves as a regulatory announcement rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-10-13 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.